Jawad Salman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jawad Salman has a total of 223 co-authors. Here are the top co-authors by number of shared publications:
- Fabio Ius
Department of Cardiothoracic, Transplant, and Vascular Surgery, Hannover Medical School, Hannover, Germany
26 shared publications - Arjang Ruhparwar
Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
13 shared publications - Bastian Schmack
Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
11 shared publications - Mark Greer
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany
11 shared publications - Alina Zubarevich
Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
10 shared publications Murat Avsar
Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School , Hannover, 30625
10 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Springer Nature in La radiologia medica
- Vol. 131 (10) , 1804-1818
Early post-transplant ventilation and perfusion assessment using phase-resolved functional lung MRI
Purpose: Post-transplant functional lung surveillance relies on global ventilatory assessment using spirometry, lacking regional ventilation and perfusion measures. We aimed to assess early post-transplant lung function in clinically stable recipients using phase-resolved functional lung (PREFUL) MRI. Material and methods: In this prospective, single-center study (March 2022–December 2024), clinically stable bilateral lung transplant recipients and 1:1 age- (± 5 years) sex-matched participants ( n = 100) underwent PREFUL MRI and spirometry. Ventilation and perfusion MRI was voxel-based quantified: Regional ventilation (RVent, [mL/mL]), flow-volume loop ventilation (FVL, [au]) and perfusion (Q, [mL/min/100 mL]). Whole lung defect maps (VDP, QDP [%]), V/Q ratios (%) based on RVent, FVL and Q were generated. Median MRI parameters were compared with controls, spirometry and perioperative data (Bonferroni correction P<.0045 considered significant). Results: 84 participants (42 transplant recipients and 42 healthy participants) were evaluated at median 16 days post-transplantation. In lung transplant recipients RVent, FVL and Q did not differ from controls (all P > 0.01). Transplant recipients demonstrated increased RVent VDP (10% vs 3.7%, P < 0.001), VDP combined (14% vs 7.1%, P < 0.001) and QDP (7.9% vs 2.4%, P < 0.001). In transplant recipients FVL, FVL VDP, QDP and V/Q matched defects correlated with spirometry. QDP was associated with prolonged cold ischemic times of first lung allografts ( ρ = 0.43, P = 0.004), V/Q mismatch with cold ischemic times of first and second implanted lungs ( ρ = 0.48, P = 0.001; ρ = 0.46, P = 0.002). Conclusion: Free-breathing phase-resolved functional lung MRI-derived parameters revealed increased regional ventilation and perfusion heterogeneity in stable lung transplant recipients two weeks post-transplantation and correlated with spirometry and prolonged cold ischemic times of allografts.
- 18 September 2026
- Published by Springer Nature in La radiologia medica
- Vol. 131 (10) , 1804-1818
Open AccessEarly post-transplant ventilation and perfusion assessment using phase-resolved functional lung MRI
Purpose: Post-transplant functional lung surveillance relies on global ventilatory assessment using spirometry, lacking regional ventilation and perfusion measures. We aimed to assess early post-transplant lung function in clinically stable recipients using phase-resolved functional lung (PREFUL) MRI. Material and methods: In this prospective, single-center study (March 2022–December 2024), clinically stable bilateral lung transplant recipients and 1:1 age- (± 5 years) sex-matched participants ( n = 100) underwent PREFUL MRI and spirometry. Ventilation and perfusion MRI was voxel-based quantified: Regional ventilation (RVent, [mL/mL]), flow-volume loop ventilation (FVL, [au]) and perfusion (Q, [mL/min/100 mL]). Whole lung defect maps (VDP, QDP [%]), V/Q ratios (%) based on RVent, FVL and Q were generated. Median MRI parameters were compared with controls, spirometry and perioperative data (Bonferroni correction P<.0045 considered significant). Results: 84 participants (42 transplant recipients and 42 healthy participants) were evaluated at median 16 days post-transplantation. In lung transplant recipients RVent, FVL and Q did not differ from controls (all P > 0.01). Transplant recipients demonstrated increased RVent VDP (10% vs 3.7%, P < 0.001), VDP combined (14% vs 7.1%, P < 0.001) and QDP (7.9% vs 2.4%, P < 0.001). In transplant recipients FVL, FVL VDP, QDP and V/Q matched defects correlated with spirometry. QDP was associated with prolonged cold ischemic times of first lung allografts ( ρ = 0.43, P = 0.004), V/Q mismatch with cold ischemic times of first and second implanted lungs ( ρ = 0.48, P = 0.001; ρ = 0.46, P = 0.002). Conclusion: Free-breathing phase-resolved functional lung MRI-derived parameters revealed increased regional ventilation and perfusion heterogeneity in stable lung transplant recipients two weeks post-transplantation and correlated with spirometry and prolonged cold ischemic times of allografts.
- Open Access
- 3 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6821
Sex Disparities in Outcomes After Minimally Invasive Direct CABG for Single-Vessel Disease: A Propensity Score-Matched Analysis
Background: Female sex is widely regarded as an independent risk factor for adverse outcomes after conventional coronary artery bypass grafting (CABG) and is incorporated as a risk variable in EuroSCORE II. Whether this disadvantage persists in the setting of minimally invasive direct coronary artery bypass (MIDCAB), in which sternotomy and cardiopulmonary bypass are avoided, remains insufficiently characterised. We assessed sex-specific short- and long-term outcomes after MIDCAB in a single-centre cohort with extended follow-up. Methods: We retrospectively analysed 350 consecutive patients who underwent MIDCAB at Hannover Medical School between July 1999 and April 2025 (follow-up to April 2025). Eligibility criteria and heart team-applied exclusion criteria (prior left thoracotomy, unfavourable LAD anatomy, prohibitive respiratory reserve, hostile chest wall, active endocarditis, or haemodynamic instability requiring on-pump revascularization) are detailed in the Methods. Females (n = 102) and males (n = 248) were compared before and after 1:1 propensity score matching using greedy nearest-neighbour matching with a caliper of 0.2 × SD of the logit propensity score. The primary endpoint was all-cause long-term mortality; secondary endpoints included perioperative complications and in-hospital outcomes. Long-term survival was assessed by Kaplan–Meier analysis and multivariable Cox proportional hazards regression performed in the full unmatched cohort. A pre-specified subgroup analysis of long-term survival by coronary disease pattern (single-vessel vs. multivessel disease) was also performed. Results: Matching produced 100 female–male pairs with excellent covariate balance (all standardized mean differences < 0.20). MIDCAB was completed without intraoperative conversion in all patients. Thirty-day mortality was 0% in both sexes; no postoperative stroke or new requirement for dialysis occurred. New-onset atrial fibrillation (3.0% vs. 1.0%, p = 0.621), length of intensive care unit stay (median 1 day in both groups), and hospital length of stay (median 8 days in both groups) were comparable between females and males. Re-exploration for bleeding was numerically more frequent in women (5.0% vs. 0.0%; Newcombe 95% CI for the risk difference +0.3 to +11.2%; Fisher’s exact p = 0.059). At a median follow-up of 19.0 years (IQR 11.8–23.9), all-cause mortality was identical (12.0% vs. 12.0%, p = 1.000; log-rank p = 0.703). In multivariable Cox regression in the full unmatched cohort, female sex was not associated with long-term mortality (adjusted HR 0.80, 95% CI 0.38–1.70, p = 0.560); only advancing age emerged as a strong independent predictor (HR 1.10 per year, 95% CI 1.05–1.15, p < 0.001), with EuroSCORE II approaching significance (HR 1.67 per unit, 95% CI 1.00–2.82, p = 0.052). Long-term survival in patients with multivessel disease (20-year Kaplan–Meier 90.9%) was equivalent to that in single-vessel disease (92.3%; log-rank p = 0.94). Conclusions: In this propensity-matched analysis with two decades of follow-up, MIDCAB conferred equivalent perioperative safety and long-term survival in women and men. Female sex was not an independent predictor of adverse outcome. These findings support MIDCAB as a sex-neutral revascularization strategy for single-vessel and LAD-predominant coronary artery disease in the very low-risk, appropriately selected population studied, and are consistent with the most recent published MIDCAB literature.
- 3 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6821
Open AccessSex Disparities in Outcomes After Minimally Invasive Direct CABG for Single-Vessel Disease: A Propensity Score-Matched Analysis
Background: Female sex is widely regarded as an independent risk factor for adverse outcomes after conventional coronary artery bypass grafting (CABG) and is incorporated as a risk variable in EuroSCORE II. Whether this disadvantage persists in the setting of minimally invasive direct coronary artery bypass (MIDCAB), in which sternotomy and cardiopulmonary bypass are avoided, remains insufficiently characterised. We assessed sex-specific short- and long-term outcomes after MIDCAB in a single-centre cohort with extended follow-up. Methods: We retrospectively analysed 350 consecutive patients who underwent MIDCAB at Hannover Medical School between July 1999 and April 2025 (follow-up to April 2025). Eligibility criteria and heart team-applied exclusion criteria (prior left thoracotomy, unfavourable LAD anatomy, prohibitive respiratory reserve, hostile chest wall, active endocarditis, or haemodynamic instability requiring on-pump revascularization) are detailed in the Methods. Females (n = 102) and males (n = 248) were compared before and after 1:1 propensity score matching using greedy nearest-neighbour matching with a caliper of 0.2 × SD of the logit propensity score. The primary endpoint was all-cause long-term mortality; secondary endpoints included perioperative complications and in-hospital outcomes. Long-term survival was assessed by Kaplan–Meier analysis and multivariable Cox proportional hazards regression performed in the full unmatched cohort. A pre-specified subgroup analysis of long-term survival by coronary disease pattern (single-vessel vs. multivessel disease) was also performed. Results: Matching produced 100 female–male pairs with excellent covariate balance (all standardized mean differences < 0.20). MIDCAB was completed without intraoperative conversion in all patients. Thirty-day mortality was 0% in both sexes; no postoperative stroke or new requirement for dialysis occurred. New-onset atrial fibrillation (3.0% vs. 1.0%, p = 0.621), length of intensive care unit stay (median 1 day in both groups), and hospital length of stay (median 8 days in both groups) were comparable between females and males. Re-exploration for bleeding was numerically more frequent in women (5.0% vs. 0.0%; Newcombe 95% CI for the risk difference +0.3 to +11.2%; Fisher’s exact p = 0.059). At a median follow-up of 19.0 years (IQR 11.8–23.9), all-cause mortality was identical (12.0% vs. 12.0%, p = 1.000; log-rank p = 0.703). In multivariable Cox regression in the full unmatched cohort, female sex was not associated with long-term mortality (adjusted HR 0.80, 95% CI 0.38–1.70, p = 0.560); only advancing age emerged as a strong independent predictor (HR 1.10 per year, 95% CI 1.05–1.15, p < 0.001), with EuroSCORE II approaching significance (HR 1.67 per unit, 95% CI 1.00–2.82, p = 0.052). Long-term survival in patients with multivessel disease (20-year Kaplan–Meier 90.9%) was equivalent to that in single-vessel disease (92.3%; log-rank p = 0.94). Conclusions: In this propensity-matched analysis with two decades of follow-up, MIDCAB conferred equivalent perioperative safety and long-term survival in women and men. Female sex was not an independent predictor of adverse outcome. These findings support MIDCAB as a sex-neutral revascularization strategy for single-vessel and LAD-predominant coronary artery disease in the very low-risk, appropriately selected population studied, and are consistent with the most recent published MIDCAB literature.
- Open Access
- 8 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6159
Feasibility, Acceptability and Early Outcomes of Concomitant Aortic and Mitral Valve Surgery via a Single-Incision Right Anterior Minithoracotomy: A Retrospective Cohort Study
Background: Minimally invasive approaches for multivalve surgery have attracted increasing interest; however, data on combined aortic and mitral valve replacement or repair using via right anterior minithoracotomy remain quite limited. This study aimed to evaluate the feasibility, safety, and early outcomes of minimally invasive concomitant aortic and mitral valve replacement or repair using this approach. Methods: This retrospective study included 24 patients who underwent simultaneous aortic and mitral valve procedures via right anterior minithoracotomy. We collected preoperative, intraoperative, and postoperative data, assessing echocardiographic parameters. Early clinical outcomes, complications, and mortality rates were analyzed, with correlations between EuroSCORE II and outcomes explored. Results: The median follow-up was 412 days. All procedures were completed successfully without conversion to sternotomy. Postoperative echocardiography demonstrated a significant reduction in transvalvular gradients, with aortic mean pressure gradient decreasing from 51.3 ± 23.0 mmHg to 6.7 ± 1.7 mmHg (p < 0.001) and mitral mean pressure gradient from 19.3 ± 26.7 mmHg to 4.0 ± 1.4 mmHg (p < 0.001), while left ventricular ejection fraction remained unchanged (p = 0.67). During the study period, one patient died from a non-cardiac cause. EuroSCORE II showed a moderate positive correlation with intensive care unit length of stay (p = 0.011) but not with hospital stay or operative times. Conclusions: Minimally invasive aortic and mitral valve replacement or repair via right anterior minithoracotomy is feasible and was associated with favorable early hemodynamic and clinical outcomes in this single-center cohort.
- 8 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6159
Open AccessFeasibility, Acceptability and Early Outcomes of Concomitant Aortic and Mitral Valve Surgery via a Single-Incision Right Anterior Minithoracotomy: A Retrospective Cohort Study
Background: Minimally invasive approaches for multivalve surgery have attracted increasing interest; however, data on combined aortic and mitral valve replacement or repair using via right anterior minithoracotomy remain quite limited. This study aimed to evaluate the feasibility, safety, and early outcomes of minimally invasive concomitant aortic and mitral valve replacement or repair using this approach. Methods: This retrospective study included 24 patients who underwent simultaneous aortic and mitral valve procedures via right anterior minithoracotomy. We collected preoperative, intraoperative, and postoperative data, assessing echocardiographic parameters. Early clinical outcomes, complications, and mortality rates were analyzed, with correlations between EuroSCORE II and outcomes explored. Results: The median follow-up was 412 days. All procedures were completed successfully without conversion to sternotomy. Postoperative echocardiography demonstrated a significant reduction in transvalvular gradients, with aortic mean pressure gradient decreasing from 51.3 ± 23.0 mmHg to 6.7 ± 1.7 mmHg (p < 0.001) and mitral mean pressure gradient from 19.3 ± 26.7 mmHg to 4.0 ± 1.4 mmHg (p < 0.001), while left ventricular ejection fraction remained unchanged (p = 0.67). During the study period, one patient died from a non-cardiac cause. EuroSCORE II showed a moderate positive correlation with intensive care unit length of stay (p = 0.011) but not with hospital stay or operative times. Conclusions: Minimally invasive aortic and mitral valve replacement or repair via right anterior minithoracotomy is feasible and was associated with favorable early hemodynamic and clinical outcomes in this single-center cohort.
- Open Access
- 3 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6043
Early and Long-Term Outcomes of Minimally Invasive Direct Coronary Artery Bypass in Elderly Patients: A Propensity Score-Matched Analysis
Background: Advancing age is incorporated as a strong risk variable in EuroSCORE II and is consistently associated with adverse outcomes after conventional coronary artery bypass grafting (CABG). Whether minimally invasive direct coronary artery bypass (MIDCAB)—which avoids both sternotomy and cardiopulmonary bypass—modifies this age-related risk in patients with single-vessel or LAD-predominant coronary artery disease remains insufficiently characterised. Methods: We retrospectively analysed 350 consecutive patients who underwent MIDCAB at Hannover Medical School between July 1999 and April 2025 (follow-up to April 2025). Elderly patients (age ≥70 years; n = 117) were compared with younger patients (age p = 0.002; log-rank p = 0.001; exact McNemar’s p = 0.0025 for the matched-pair mortality endpoint). After multivariable adjustment, elderly age (≥70 years) was independently associated with long-term mortality (adjusted hazard ratio 4.48, 95% CI 1.79–11.20, p = 0.001), as was EuroSCORE II (HR 2.40 per unit, p = 0.034); a pre-specified parsimonious model (age, LVEF, renal impairment) with pair-cluster robust standard errors yielded an essentially identical adjusted HR for elderly age of 4.08 (95% CI 1.65–10.04, p = 0.002), and a sensitivity propensity model without EuroSCORE II yielded HR 3.95 (95% CI 1.68–9.29, p = 0.002). Conclusions: In this propensity-matched analysis with a median follow-up of ~19 years, MIDCAB was associated with excellent observed perioperative outcomes in appropriately selected elderly patients (no 30-day mortality, stroke, or new dialysis observed; upper 95% CI 3.3%) and no evidence of an excess of major in-hospital complications compared with younger patients within the statistical resolution of the cohort. The long-term mortality excess in the elderly is consistent with age-related life-expectancy curves in the source population; cause-specific mortality was not available in this cohort. External benchmarks from large MIDCAB cohorts in which long-term survival approximates that of the age-matched general population support this interpretation indirectly. These findings support MIDCAB as a feasible revascularization strategy associated with favourable observed early outcomes and long-term survival consistent with published MIDCAB literature, in appropriately selected elderly patients with single-vessel or LAD-predominant coronary artery disease treated at experienced centres.
- 3 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6043
Open AccessEarly and Long-Term Outcomes of Minimally Invasive Direct Coronary Artery Bypass in Elderly Patients: A Propensity Score-Matched Analysis
Background: Advancing age is incorporated as a strong risk variable in EuroSCORE II and is consistently associated with adverse outcomes after conventional coronary artery bypass grafting (CABG). Whether minimally invasive direct coronary artery bypass (MIDCAB)—which avoids both sternotomy and cardiopulmonary bypass—modifies this age-related risk in patients with single-vessel or LAD-predominant coronary artery disease remains insufficiently characterised. Methods: We retrospectively analysed 350 consecutive patients who underwent MIDCAB at Hannover Medical School between July 1999 and April 2025 (follow-up to April 2025). Elderly patients (age ≥70 years; n = 117) were compared with younger patients (age p = 0.002; log-rank p = 0.001; exact McNemar’s p = 0.0025 for the matched-pair mortality endpoint). After multivariable adjustment, elderly age (≥70 years) was independently associated with long-term mortality (adjusted hazard ratio 4.48, 95% CI 1.79–11.20, p = 0.001), as was EuroSCORE II (HR 2.40 per unit, p = 0.034); a pre-specified parsimonious model (age, LVEF, renal impairment) with pair-cluster robust standard errors yielded an essentially identical adjusted HR for elderly age of 4.08 (95% CI 1.65–10.04, p = 0.002), and a sensitivity propensity model without EuroSCORE II yielded HR 3.95 (95% CI 1.68–9.29, p = 0.002). Conclusions: In this propensity-matched analysis with a median follow-up of ~19 years, MIDCAB was associated with excellent observed perioperative outcomes in appropriately selected elderly patients (no 30-day mortality, stroke, or new dialysis observed; upper 95% CI 3.3%) and no evidence of an excess of major in-hospital complications compared with younger patients within the statistical resolution of the cohort. The long-term mortality excess in the elderly is consistent with age-related life-expectancy curves in the source population; cause-specific mortality was not available in this cohort. External benchmarks from large MIDCAB cohorts in which long-term survival approximates that of the age-matched general population support this interpretation indirectly. These findings support MIDCAB as a feasible revascularization strategy associated with favourable observed early outcomes and long-term survival consistent with published MIDCAB literature, in appropriately selected elderly patients with single-vessel or LAD-predominant coronary artery disease treated at experienced centres.
- Open Access
Cardioplegia Strategies in Minimally Invasive Aortic Valve Replacement: An Inverse Probability of Treatment Weighting Analysis
Background and Objectives: Optimal myocardial protection during minimally invasive aortic valve replacement (MIAVR) is debated. We compared four cardioplegia strategies. Materials and Methods: Consecutive MIAVR patients (January 2010–April 2025) at a single centre were analysed retrospectively. Cardioplegia regimens were Buckberg (n = 131), Calafiore (n = 153), Custodiol HTK (n = 146) and St Thomas’ (n = 113). Because substantial baseline imbalances were present in the unadjusted cohort, inverse probability of treatment weighting (IPTW) based on a multinomial propensity score was applied to achieve covariate balance between groups. IPTW was performed using a comprehensive propensity model that incorporated (1) baseline demographic and clinical characteristics, (2) anatomical factors, including bicuspid valve morphology. Procedural time variables were assessed in secondary sensitivity analyses. After IPTW application, all variables, including procedural times, achieved balance (ASMD < 0.1). Postoperative outcomes were then compared in this fully balanced pseudo-population. The Scheffé post hoc test was performed. Results: Groups were demographically comparable except for more bicuspid valves in Buckberg. New-onset paroxysmal atrial fibrillation occurred in 31.2% (Buckberg) and 26.5% (St Thomas’) versus 7.1% (Calafiore) and 2.0% (Custodiol) (p < 0.01). Respiratory insufficiency followed a similar pattern (p = 0.02). Intensive-care and hospital stay, major complications, left-ventricular ejection fraction, and 30-day mortality (0.6–3.0%) were equivalent. Bicuspid anatomy independently prolonged operative metrics but did not influence biomarkers. Conclusions: After comprehensive inverse probability weighting that balanced groups on all baseline characteristics and anatomical factors, Calafiore and Custodiol cardioplegia strategies maintained significantly lower rates of new-onset atrial fibrillation (9.3% and 3.8% vs. 28.5% for Buckberg, p < 0.01), reduced myocardial injury biomarker release (peak CK 520 and 510 vs. 920 U/L, p < 0.01), and decreased respiratory complications (7.8% and 8.1% vs. 16.2%, p = 0.01), while mortality, stroke, and resource utilisation measures remained comparable across strategies.
Open AccessCardioplegia Strategies in Minimally Invasive Aortic Valve Replacement: An Inverse Probability of Treatment Weighting Analysis
Background and Objectives: Optimal myocardial protection during minimally invasive aortic valve replacement (MIAVR) is debated. We compared four cardioplegia strategies. Materials and Methods: Consecutive MIAVR patients (January 2010–April 2025) at a single centre were analysed retrospectively. Cardioplegia regimens were Buckberg (n = 131), Calafiore (n = 153), Custodiol HTK (n = 146) and St Thomas’ (n = 113). Because substantial baseline imbalances were present in the unadjusted cohort, inverse probability of treatment weighting (IPTW) based on a multinomial propensity score was applied to achieve covariate balance between groups. IPTW was performed using a comprehensive propensity model that incorporated (1) baseline demographic and clinical characteristics, (2) anatomical factors, including bicuspid valve morphology. Procedural time variables were assessed in secondary sensitivity analyses. After IPTW application, all variables, including procedural times, achieved balance (ASMD < 0.1). Postoperative outcomes were then compared in this fully balanced pseudo-population. The Scheffé post hoc test was performed. Results: Groups were demographically comparable except for more bicuspid valves in Buckberg. New-onset paroxysmal atrial fibrillation occurred in 31.2% (Buckberg) and 26.5% (St Thomas’) versus 7.1% (Calafiore) and 2.0% (Custodiol) (p < 0.01). Respiratory insufficiency followed a similar pattern (p = 0.02). Intensive-care and hospital stay, major complications, left-ventricular ejection fraction, and 30-day mortality (0.6–3.0%) were equivalent. Bicuspid anatomy independently prolonged operative metrics but did not influence biomarkers. Conclusions: After comprehensive inverse probability weighting that balanced groups on all baseline characteristics and anatomical factors, Calafiore and Custodiol cardioplegia strategies maintained significantly lower rates of new-onset atrial fibrillation (9.3% and 3.8% vs. 28.5% for Buckberg, p < 0.01), reduced myocardial injury biomarker release (peak CK 520 and 510 vs. 920 U/L, p < 0.01), and decreased respiratory complications (7.8% and 8.1% vs. 16.2%, p = 0.01), while mortality, stroke, and resource utilisation measures remained comparable across strategies.
- Open Access
- 5 February 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (2)
Elective Use of Intraoperative Extracorporeal Membrane Oxygenation in Patients With Pulmonary Fibrosis Reduces Primary Graft Dysfunction After Bilateral Lung Transplantation
Objectives: This study presents the 5-year experience with a more liberal intraoperative extracorporeal membrane oxygenation (ECMO) elective support in patients with pulmonary fibrosis (PF) undergoing lung transplantation (LTx). Methods: Patients with PF undergoing LTx between January 2012 and January 2025 were included and sub-divided into the period before and after the implementation of a more liberal intraoperative use of ECMO support in January 2020. Outcomes were compared between elective, non-elective, and no intraoperative ECMO in both periods. Previously-identified parameters as decision criteria for elective ECMO were examined. Results: Overall, 422 PF patients underwent LTx, of whom 273 patients were transplanted before 2020 (elective ECMO, n = 52 (19%); non-elective ECMO, n = 30 (11%); no ECMO, n = 191 (70%)) and 149 patients were transplanted since 2020 (elective intraoperative ECMO, n = 98 (66%); non-elective ECMO, n = 12 (8%); no ECMO, n = 39 (26%)). After 2020, elective ECMO was increasingly used in patients with mean pulmonary arterial pressure >50 mmHg and pulmonary vascular resistance >9.4 WU. However, 8% were not identified based on these parameters and still required non-elective ECMO. Comparing pre- and post-2020, primary graft dysfunction (PGD) grade 3 72 h post-transplant between elective (17% vs 3%, P = .002), non-elective (38% vs 0%, P = .016), and no ECMO (12% vs 3%, P = .078) was significant reduced. One-year graft survival in elective (88.5% vs 95.6%), non-elective (70% vs 91.7%), and no ECMO (92.7% vs 94.9%) showed a trend towards improved survival. Conclusions: The use of a more liberal, elective intraoperative ECMO support in patients with PF led to an improvement of PGD prevalence and survival early after lung transplantation.
- 5 February 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (2)
Open AccessElective Use of Intraoperative Extracorporeal Membrane Oxygenation in Patients With Pulmonary Fibrosis Reduces Primary Graft Dysfunction After Bilateral Lung Transplantation
Objectives: This study presents the 5-year experience with a more liberal intraoperative extracorporeal membrane oxygenation (ECMO) elective support in patients with pulmonary fibrosis (PF) undergoing lung transplantation (LTx). Methods: Patients with PF undergoing LTx between January 2012 and January 2025 were included and sub-divided into the period before and after the implementation of a more liberal intraoperative use of ECMO support in January 2020. Outcomes were compared between elective, non-elective, and no intraoperative ECMO in both periods. Previously-identified parameters as decision criteria for elective ECMO were examined. Results: Overall, 422 PF patients underwent LTx, of whom 273 patients were transplanted before 2020 (elective ECMO, n = 52 (19%); non-elective ECMO, n = 30 (11%); no ECMO, n = 191 (70%)) and 149 patients were transplanted since 2020 (elective intraoperative ECMO, n = 98 (66%); non-elective ECMO, n = 12 (8%); no ECMO, n = 39 (26%)). After 2020, elective ECMO was increasingly used in patients with mean pulmonary arterial pressure >50 mmHg and pulmonary vascular resistance >9.4 WU. However, 8% were not identified based on these parameters and still required non-elective ECMO. Comparing pre- and post-2020, primary graft dysfunction (PGD) grade 3 72 h post-transplant between elective (17% vs 3%, P = .002), non-elective (38% vs 0%, P = .016), and no ECMO (12% vs 3%, P = .078) was significant reduced. One-year graft survival in elective (88.5% vs 95.6%), non-elective (70% vs 91.7%), and no ECMO (92.7% vs 94.9%) showed a trend towards improved survival. Conclusions: The use of a more liberal, elective intraoperative ECMO support in patients with PF led to an improvement of PGD prevalence and survival early after lung transplantation.
- Open Access
- 2 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 354
Minimally Invasive Aortic Valve Replacement in Elderly Patients: Insights from a Large Cohort
Background/Objectives: Transcatheter aortic valve implantation (TAVI) has become the leading treatment option for patients suffering from aortic valve stenosis aged over 70, except in cases of specific contraindications like bicuspid valves, inappropriate access routes, or endocarditis. Minimally invasive aortic valve replacement (MIAVR) has emerged as a potential way to combine the durability of surgery with reduced procedural trauma. This study aims to assess the safety and feasibility of MIAVR in elderly patients. Methods: A total of 990 patients were included in this retrospective cohort study. Among them, 261 (26%) were aged 70 years or older (elderly cohort), and 729 (74%) were younger than 70 years (younger cohort). All patients were followed for at least 30 days postoperatively, with survival data collected through May 2025. Multivariable logistic regression, linear regression, and Kaplan–Meier survival analyses were performed. Results: Elderly patients were more likely to be female (51% vs. 40%, p = 0.001) and carried a heavier burden of vascular and renal comorbidity: renal impairment 33% vs. 17% and extracardiac arteriopathy 45% vs. 30% (both p < 0.001). Major bleeding occurred more frequently in the elderly cohort (7.7% vs. 4.1%; p = 0.02), as did new permanent pacemaker implantation (10% vs. 5.8%; p = 0.021) and sepsis (3.4% vs. 1.1%; p = 0.012). Rates of stroke, perioperative myocardial infarction, ECMO/right-heart failure, re-thoracotomy, and postoperative dialysis were low and comparable across age groups (all p > 0.20). Overall, 30-day mortality was 2.4% (24/990), with crude mortality approximately threefold higher among patients aged ≥70 years (4.6% vs. 1.6%). Conclusions: Our findings indicate that MIAVR is a feasible and safe surgical option across age groups; Elevated morbidity in elderly patients is primarily due to bleeding, pacemaker implantation, and sepsis, while rates of stroke, renal failure, and myocardial infarction are low.
- 2 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 354
Open AccessMinimally Invasive Aortic Valve Replacement in Elderly Patients: Insights from a Large Cohort
Background/Objectives: Transcatheter aortic valve implantation (TAVI) has become the leading treatment option for patients suffering from aortic valve stenosis aged over 70, except in cases of specific contraindications like bicuspid valves, inappropriate access routes, or endocarditis. Minimally invasive aortic valve replacement (MIAVR) has emerged as a potential way to combine the durability of surgery with reduced procedural trauma. This study aims to assess the safety and feasibility of MIAVR in elderly patients. Methods: A total of 990 patients were included in this retrospective cohort study. Among them, 261 (26%) were aged 70 years or older (elderly cohort), and 729 (74%) were younger than 70 years (younger cohort). All patients were followed for at least 30 days postoperatively, with survival data collected through May 2025. Multivariable logistic regression, linear regression, and Kaplan–Meier survival analyses were performed. Results: Elderly patients were more likely to be female (51% vs. 40%, p = 0.001) and carried a heavier burden of vascular and renal comorbidity: renal impairment 33% vs. 17% and extracardiac arteriopathy 45% vs. 30% (both p < 0.001). Major bleeding occurred more frequently in the elderly cohort (7.7% vs. 4.1%; p = 0.02), as did new permanent pacemaker implantation (10% vs. 5.8%; p = 0.021) and sepsis (3.4% vs. 1.1%; p = 0.012). Rates of stroke, perioperative myocardial infarction, ECMO/right-heart failure, re-thoracotomy, and postoperative dialysis were low and comparable across age groups (all p > 0.20). Overall, 30-day mortality was 2.4% (24/990), with crude mortality approximately threefold higher among patients aged ≥70 years (4.6% vs. 1.6%). Conclusions: Our findings indicate that MIAVR is a feasible and safe surgical option across age groups; Elevated morbidity in elderly patients is primarily due to bleeding, pacemaker implantation, and sepsis, while rates of stroke, renal failure, and myocardial infarction are low.
- 3 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (11)
Lung Allograft Size Matching According to Actual, Corrected, and Predicted Total Lung Capacity for Patients With Pulmonary Fibrosis
Objectives: Donor-recipient size matching in patients with pulmonary fibrosis may be performed according to the actual total lung capacity (aTLC) as measured by body plethysmography, the corrected total lung capacity (cTLC), and the predicted total lung capacity (pTLC). However, there is still no consensus on the ideal matching total lung capacity. Therefore, we aimed to analyse post-transplant outcomes of patients with pulmonary fibrosis listed according to aTLC, cTLC, or pTLC. Methods: Patient records were retrospectively reviewed and analysed using Bayesian statistics. Patients with pulmonary fibrosis who underwent double lung transplantation without concomitant lung reduction surgery were included. Results: Between November 2017 and May 2023, among the 521 patients who underwent lung transplantation at our institution, 122 (24%) were included, with 11 (9%) forming the aTLC group, 21 (17%) forming the cTLC group, and 90 (74%) forming the pTLC group. Overall patient and graft mortality was decreased in patients who were listed according to aTLC when compared to cTLC (HR 0.11; 95% CrI 0-0.99). However, Bayesian Cox multivariable analysis revealed that this was due to the higher incidence of associated pulmonary hypertension and chronic renal failure in the cTLC group. No difference was seen in the incidence of biopsy-confirmed rejection and chronic lung allograft dysfunction. Conclusions: Our study showed that listing patients according to aTLC improved mortality when compared to listing according to cTLC, because patients listed according to cTLC had a higher preoperative morbidity.
- 3 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (11)
Lung Allograft Size Matching According to Actual, Corrected, and Predicted Total Lung Capacity for Patients With Pulmonary Fibrosis
Objectives: Donor-recipient size matching in patients with pulmonary fibrosis may be performed according to the actual total lung capacity (aTLC) as measured by body plethysmography, the corrected total lung capacity (cTLC), and the predicted total lung capacity (pTLC). However, there is still no consensus on the ideal matching total lung capacity. Therefore, we aimed to analyse post-transplant outcomes of patients with pulmonary fibrosis listed according to aTLC, cTLC, or pTLC. Methods: Patient records were retrospectively reviewed and analysed using Bayesian statistics. Patients with pulmonary fibrosis who underwent double lung transplantation without concomitant lung reduction surgery were included. Results: Between November 2017 and May 2023, among the 521 patients who underwent lung transplantation at our institution, 122 (24%) were included, with 11 (9%) forming the aTLC group, 21 (17%) forming the cTLC group, and 90 (74%) forming the pTLC group. Overall patient and graft mortality was decreased in patients who were listed according to aTLC when compared to cTLC (HR 0.11; 95% CrI 0-0.99). However, Bayesian Cox multivariable analysis revealed that this was due to the higher incidence of associated pulmonary hypertension and chronic renal failure in the cTLC group. No difference was seen in the incidence of biopsy-confirmed rejection and chronic lung allograft dysfunction. Conclusions: Our study showed that listing patients according to aTLC improved mortality when compared to listing according to cTLC, because patients listed according to cTLC had a higher preoperative morbidity.
- Open Access
- 22 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6666
Minimally Invasive Mitral Valve Replacement in the Gray Zone: Bioprosthetic vs. Mechanical Valves in Patients Aged 50–69 Years
Background: Mitral valve replacement presents considerable challenges in the field of cardiothoracic surgery, particularly in patients aged 50 to 69, where the decision between bioprosthetic and mechanical valves is critical. Nevertheless, the optimal selection of prosthetic valves for candidates within this age-related gray zone remains inadequately defined, necessitating a thorough evaluation of long-term outcomes and associated risks. Objective: This study aims to assess mid-term outcomes of MIMVR in patients aged 50 to 69, comparing reoperation rates, prosthesis-related morbidity, and overall survival between bioprosthetic and mechanical valves. While many prior studies on valve choice in patients aged 50 to 69 years are derived from sternotomy cohorts, the novelty of our work lies in the exclusive focus on patients undergoing minimally invasive techniques. Methods: A retrospective analysis was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, including 172 patients aged 50–69 years who underwent minimally invasive mitral valve replacement via right minithoracotomy at a high-volume center in Germany between 2011 and 2023. Of the 172 patients, 95 underwent MIMVR using biological prostheses, while 77 received mechanical prostheses. Comprehensive data on demographics, surgical procedures, and postoperative complications, as well as long-term outcomes, were analyzed. Results: With a mean follow-up of 7.1 years, early outcomes revealed no significant differences in 30-day mortality (7.4% for bioprosthetic vs. 2.6% for mechanical; p = 0.06). There was no significant differences in all-cause mortality at 1 year (8.4% vs. 3.9%; p = 0.22), 3-year (9.5% vs. 7.8%; p = 0.69), and 5-year (13.7% vs. 10.4%; p = 0.19), or at the longest follow-up (13.7% vs. 10.4%; p = 0.51). Kaplan–Meier analysis showed no significant difference in long-term survival between the groups (p = 0.5427). Postoperative arrhythmia occurred significantly more frequently in the biologic group compared to the mechanical group (18.9% vs. 6.5%; p = 0.01). Conclusions: For patients aged 50–69 undergoing MIMVR using a bioprosthetic or mechanical valve, the mid-term survival and incidence of reoperation and re-hospitalization were comparable up to 7 years. This provides evidence supporting the safe application of the MICS approach with either valve type in this gray-zone age group.
- 22 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6666
Open AccessMinimally Invasive Mitral Valve Replacement in the Gray Zone: Bioprosthetic vs. Mechanical Valves in Patients Aged 50–69 Years
Background: Mitral valve replacement presents considerable challenges in the field of cardiothoracic surgery, particularly in patients aged 50 to 69, where the decision between bioprosthetic and mechanical valves is critical. Nevertheless, the optimal selection of prosthetic valves for candidates within this age-related gray zone remains inadequately defined, necessitating a thorough evaluation of long-term outcomes and associated risks. Objective: This study aims to assess mid-term outcomes of MIMVR in patients aged 50 to 69, comparing reoperation rates, prosthesis-related morbidity, and overall survival between bioprosthetic and mechanical valves. While many prior studies on valve choice in patients aged 50 to 69 years are derived from sternotomy cohorts, the novelty of our work lies in the exclusive focus on patients undergoing minimally invasive techniques. Methods: A retrospective analysis was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, including 172 patients aged 50–69 years who underwent minimally invasive mitral valve replacement via right minithoracotomy at a high-volume center in Germany between 2011 and 2023. Of the 172 patients, 95 underwent MIMVR using biological prostheses, while 77 received mechanical prostheses. Comprehensive data on demographics, surgical procedures, and postoperative complications, as well as long-term outcomes, were analyzed. Results: With a mean follow-up of 7.1 years, early outcomes revealed no significant differences in 30-day mortality (7.4% for bioprosthetic vs. 2.6% for mechanical; p = 0.06). There was no significant differences in all-cause mortality at 1 year (8.4% vs. 3.9%; p = 0.22), 3-year (9.5% vs. 7.8%; p = 0.69), and 5-year (13.7% vs. 10.4%; p = 0.19), or at the longest follow-up (13.7% vs. 10.4%; p = 0.51). Kaplan–Meier analysis showed no significant difference in long-term survival between the groups (p = 0.5427). Postoperative arrhythmia occurred significantly more frequently in the biologic group compared to the mechanical group (18.9% vs. 6.5%; p = 0.01). Conclusions: For patients aged 50–69 undergoing MIMVR using a bioprosthetic or mechanical valve, the mid-term survival and incidence of reoperation and re-hospitalization were comparable up to 7 years. This provides evidence supporting the safe application of the MICS approach with either valve type in this gray-zone age group.